For a long time, clinicians have struggled to find viable solutions for severe depressive illness . Now suggests esketamine therapy, provided typically intravenously , can offer a significant opportunity for individuals who haven't seen results from standard antidepressants . Although largely considered a developing intervention, initial studies ar